Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is 208.63% vs 1,283.09% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is -83.64% vs -54.52% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 29.62% vs 43.92% in Mar 2025
Compare Balance Sheet Results of Astrazeneca Phar
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.00
15.90
-10.90
-68.55%
Share Warrants & Outstandings
Total Reserve
867.79
2,296.40
-1,428.61
-62.21%
Shareholder's Funds
872.79
2,312.30
-1,439.51
-62.25%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
50.00
-50.00
-100.00%
Secured Loans
0.00
50.00
-50.00
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-37.80
-45.50
7.70
16.92%
Other Long Term Liabilities
118.67
1.50
117.17
7,811.33%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
15.83
12.20
3.63
29.75%
Total Non-Current Liabilities
96.70
18.20
78.50
431.32%
Current Liabilities
Trade Payables
782.70
8.70
774.00
8,896.55%
Other Current Liabilities
143.19
42.70
100.49
235.34%
Short Term Borrowings
0.00
0.00
0.00
0.00%
Short Term Provisions
55.92
5.30
50.62
955.09%
Total Current Liabilities
981.81
56.70
925.11
1,631.59%
Total Liabilities
1,951.30
2,387.20
-435.90
-18.26%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
41.46
131.90
-90.44
-68.57%
Less: Accumulated Depreciation
36.79
34.00
2.79
8.21%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
4.67
97.90
-93.23
-95.23%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
5.60
-5.60
-100.00%
Intangible assets under development
0.00
5.90
-5.90
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
2,176.00
-2,176.00
-100.00%
Long Term Loans & Advances
93.90
24.80
69.10
278.63%
Other Non Current Assets
0.00
8.10
-8.10
-100.00%
Total Non-Current Assets
211.37
2,336.30
-2,124.93
-90.95%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
1,027.33
0.00
1,027.33
0.00%
Sundry Debtors
213.68
23.80
189.88
797.82%
Cash and Bank
448.62
10.30
438.32
4,255.53%
Other Current Assets
19.96
8.80
11.16
126.82%
Short Term Loans and Advances
30.34
8.00
22.34
279.25%
Total Current Assets
1,739.93
50.90
1,689.03
3,318.33%
Net Current Assets (Including Current Investments)
758.12
-5.80
763.92
13,171.03%
Total Current Assets Excluding Current Investments
1,739.93
50.90
1,689.03
3,318.33%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
1,951.30
2,387.20
-435.90
-18.26%
Contingent Liabilities
121.23
89.20
32.03
35.91%
Total Debt
0.00
50.00
-50.00
-100.00%
Book Value per share (adjusted)
349.12
145.43
203.69
140.06%
Annual - Borrowings
No Borrowings in the last few periods
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 118.67 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 208.63% vs 1,283.09% in Mar 2025
Annual - Fixed Assets
Fixed Assets 4.67 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -83.64% vs -54.52% in Mar 2025
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 1,739.93 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 29.62% vs 43.92% in Mar 2025
